Last reviewed · How we verify

NCT03522090

Retrospective Comparative Study of Routine Lower Neck CT in the Staging and Diagnosis of Lung Cancer Across Two Cohorts

Status unknown Last updated 11 May 2018
What this trial tests

trial testing lower neck CT in Lung Cancer in 164 participants. Status unknown.

Timeline
1 July 2018
Primary endpoint
30 December 2018
30 January 2019

Quick facts

Lead sponsorUniversity College Hospital Galway
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment164
Start date1 July 2018
Primary completion30 December 2018
Estimated completion30 January 2019

Drugs / interventions tested

Conditions studied

Sponsor

University College Hospital Galway

Who can join

18 and older, any sex, with Lung Cancer or Supraclavicular Lymphadenopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a study comparing routine inclusion of the lower neck in initial CT thorax in patients with suspected lung cancer to not including it. The study aims to assess whether such an intervention reduces the number of invasive investigations required to achieve a final diagnosis and clinical stage and whether it improves the detection of cervical lymph nodes involvement by lung cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

Other University College Hospital Galway trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03522090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing